🟢 10x Genomics is trading 4.03% up, as patent-win momentum continues

10x Genomics is trading at $89.16, up 4.03%, as company-specific momentum extends its recent rally.

• Reports linked the September 24 surge to a favorable patent verdict, its Lunit AI collaboration and analyst target increases; the collaboration integrates Lunit’s pathology platform into oncology research workflows.
• No distinct new company announcement for September 28 surfaced in the search. Broader markets were weaker, pointing to company-specific momentum rather than a market-wide lift.